Cargando…

Invasive pulmonary aspergillosis in COVID-19 critically ill patients: Results of a French monocentric cohort

INTRODUCTION: Coronavirus disease 2019 or COVID-19 is a new infectious disease responsible for potentially severe respiratory impairment associated with initial immunosuppression. Similarly to influenza, several authors have described a higher risk of fungal infection after COVID-19, in particular f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Versyck, Maaike, Zarrougui, Wafa, Lambiotte, Fabien, Elbeki, Nabil, Saint-Leger, Piehr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Masson SAS. 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884920/ https://www.ncbi.nlm.nih.gov/pubmed/33621792 http://dx.doi.org/10.1016/j.mycmed.2021.101122

Ejemplares similares

Saving lives by ventilating two patients with specific pressure-controlled ventilation from a single ICU-ventilator during the COVID-19 pandemic
por: Hureau, Maxence, et al.
Publicado: (2021)

Aspergillose pulmonaire invasive chez les patients avec forme sévère de COVID-19 : résultats d’une cohorte monocentrique française
por: Saint Leger, P., et al.
Publicado: (2020)

What’s new in invasive pulmonary aspergillosis in the critically ill
por: Koulenti, Despoina, et al.
Publicado: (2014)

Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patients
por: Trof, R. J., et al.
Publicado: (2007)

Therapeutic management of severe hypothermia with veno-arterial ECMO: where do we stand? Case report and review of the current literature
por: Ledoux, Aurélien, et al.
Publicado: (2020)

Incidence of invasive pulmonary aspergillosis among critically ill COVID-19 patients
por: Lamoth, Frederic, et al.
Publicado: (2020)

Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19
por: Alanio, Alexandre, et al.
Publicado: (2020)

Severe ARDS in a critically ill influenza patient with invasive pulmonary aspergillosis
por: Pietsch, Urs, et al.
Publicado: (2016)

Invasive pulmonary aspergillosis and candidiasis in a critically ill patient with COVID-19
por: Benedetti, María Fernanda, et al.
Publicado: (2022)

A Comparison of Diagnostic Criteria for Invasive Pulmonary Aspergillosis in Critically Ill Patients
por: Liu, Rui-ting, et al.
Publicado: (2023)

The role of the critical care pharmacist during the COVID-19 pandemic
por: Lemtiri, J., et al.
Publicado: (2020)

Prise en charge COVID-19 au sein des soins critiques du plus important centre hospitalier général de France: Comment la coordination urgences, réanimation et anesthésie a permis de gérer avec succès l’épidémie de coronavirus sur le territoire valenciennois ?
por: Defrancq, Fanny, et al.
Publicado: (2020)

Prevalence and outcome of invasive pulmonary aspergillosis in critically ill patients with liver cirrhosis: an observational study
por: Lahmer, Tobias, et al.
Publicado: (2019)

Impact of Invasive Pulmonary Aspergillosis in Critically Ill Surgical Patients with or without Solid Organ Transplantation
por: Dubler, Simon, et al.
Publicado: (2023)

Cutaneous Invasive Aspergillosis: Retrospective Multicenter Study of the French Invasive-Aspergillosis Registry and Literature Review
por: Bernardeschi, Céline, et al.
Publicado: (2015)

Invasive Pulmonary Aspergillosis
por: Ledoux, Marie-Pierre, et al.
Publicado: (2023)

Putative invasive pulmonary aspergillosis in critically ill patients with chronic obstructive pulmonary disease: a matched cohort study
por: Delsuc, Claire, et al.
Publicado: (2015)

CD8(+) T-cell counts: an early predictor of risk and mortality in critically ill immunocompromised patients with invasive pulmonary aspergillosis
por: Cui, Na, et al.
Publicado: (2013)

Invasive aspergillosis in critically ill hematology patients: outcomes and prognostic factors associated with mortality
por: Burghi, G, et al.
Publicado: (2011)

Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes
por: Taccone, Fabio Silvio, et al.
Publicado: (2015)

1175. Pulmonary Aspergillosis in Critically Ill Patients with COVID-19: A Case Series
por: Mitaka, Hayato, et al.
Publicado: (2020)

Gut Microbial Disruption in Critically Ill Patients with COVID-19-Associated Pulmonary Aspergillosis
por: Maurer, H. Carlo, et al.
Publicado: (2022)

Decoding the Guidelines of Invasive Pulmonary Aspergillosis in Critical Care Setting: Imaging Perspective
por: Garg, Anisha, et al.
Publicado: (2023)

Clinical features of invasive bronchial-pulmonary aspergillosis in critically ill patients with chronic obstructive respiratory diseases: a prospective study
por: He, Hangyong, et al.
Publicado: (2011)

Invasive pulmonary aspergillosis is associated with adverse clinical outcomes in critically ill patients receiving veno-venous extracorporeal membrane oxygenation
por: Rodriguez-Goncer, I., et al.
Publicado: (2018)

Risk Factors for Invasive Pulmonary Aspergillosis in Critically Ill Patients With Coronavirus Disease 2019-Induced Acute Respiratory Distress Syndrome
por: Chauvet, Paul, et al.
Publicado: (2020)

Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study
por: Wauters, Joost, et al.
Publicado: (2012)

Differences in Clinical Characteristics of Invasive Tracheobronchial Aspergillosis according to the Presence of Invasive Pulmonary Aspergillosis
por: Pak, Chuiyong, et al.
Publicado: (2021)

Invasive aspergillosis of pulmonary hydatid cyst
por: Nabi, Buzdar M. S., et al.
Publicado: (2009)

Incidence and Risk Factors of COVID-19-Associated Pulmonary Aspergillosis in Intensive Care Unit—A Monocentric Retrospective Observational Study
por: Gregoire, Emilien, et al.
Publicado: (2021)

356. Clinical characteristics of critically ill patients with COVID-19 and invasive pulmonary aspergillosis: a case series from Mexico City
por: VALENTE-ACOSTA, Benjamin, et al.
Publicado: (2020)

Invasive pulmonary aspergillosis in critically ill patients with severe COVID-19 pneumonia: Results from the prospective AspCOVID-19 study
por: Lahmer, Tobias, et al.
Publicado: (2021)

279. Clinical Characteristics of Critically Ill Patients with COVID-19 and Invasive Pulmonary Aspergillosis: A Case Series From Mexico City
por: Galindo-Lopez, Patricia, et al.
Publicado: (2021)

Microbiological diagnosis of pulmonary invasive aspergillosis in critically ill patients with severe SARS-CoV-2 pneumonia: a bronchoalveolar study
por: Estella, Ángel, et al.
Publicado: (2023)

A Critical Reappraisal of Prolonged Neutropenia as a Risk Factor for Invasive Pulmonary Aspergillosis
por: Abers, Michael S., et al.
Publicado: (2016)

Host-Derived Leukotriene B(4) Is Critical for Resistance against Invasive Pulmonary Aspergillosis
por: Caffrey-Carr, Alayna K., et al.
Publicado: (2018)

Dapsone-induced neutropenia with invasive pulmonary aspergillosis
por: Sabnis, Girish R., et al.
Publicado: (2012)

Invasive Pulmonary Aspergillosis in an (Apparently) Immunocompetent Patient
por: Teixeira da Silva, Francisco, et al.
Publicado: (2020)

COVID-19-associated invasive pulmonary aspergillosis
por: Rutsaert, Lynn, et al.
Publicado: (2020)

Invasive pulmonary aspergillosis in a patient with cirrhosis
por: Clark, Heather L., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tgh2n76ie5ankj9n47tb6onoen